Blog
What's Behind TG Therapeutics Inc.'s 14.4% Rally in July?
Shares of TG Therapeutics Inc. (NASDAQ: TGTX) gained 14.4% in July, according to data from S&P Global Market Intelligence, despite a lack of positive announcements. It doesn't take much to move a
What Happened in the Stock Market Today
Stocks continued to climb today, with the Dow Jones Industrial Average (DJINDICES: ^DJI) securing its ninth straight record close while the S&P 500 (SNPINDEX: ^GSPC) mustered a similar modest gain.
5 Things Encana Corp's CEO Wants You to Know That Demonstrate Its Ability to Thrive at Current Prices
Encana (NYSE: ECA) recently reported blowout second-quarter results. Heading into the quarter, analysts expected that it would earn $0.04 per share. However, it blew past that estimate by posting a
Suburban Propane Partners' Earnings Mean Little Next to Its Planned Distribution Cut
It's no secret that Suburban Propane Partners' (NYSE: SPH) distribution was already preposterously high. After two straight years of record warm temperatures, the company's cash flow has been
Why On Deck Capital Stock Jumped More Than 20% on Monday
Shares of On Deck Capital (NYSE: ONDK) were up more than 21% as of 3:15 p.m. EDT, after the company announced a smaller net loss during the second quarter and a promising expansion in its partnership
3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping?
There's an old saying that a rising tide lifts all boats. That's true -- but only if the boats don't have holes in them. With the S&P 500 index hitting an all-time high recently, most stocks are
Why Teva Pharmaceutical Industries, Intrepid Potash, and Ensco Slumped Today
Monday was another good day for stocks, as major benchmarks continued their slow but steady ascent. Without much in the way of market-moving news on the geopolitical or macroeconomic fronts, investors
Why NxStage Medical, MyoKardia, and Rockwell Collins Jumped Today
The stock market kept climbing on Monday, with modest gains across major benchmarks that nevertheless sent the Dow Jones Industrial Average to its ninth straight record high. Absent major news in the
Here's Why Array BioPharma Inc. Fell 13.7% in July
Shares of Array BioPharma (NASDAQ: ARRY), a cancer-focused clinical-stage biotech, dropped nearly 14% in July, according to data from S&P Global Market Intelligence.Here's a review of the two company
What's Behind Pacific Biosciences of California's Stock Rally Today?
Shares of Pacific Biosciences of California (NASDAQ: PACB) are on the rise again. This is the third trading session in a row that the stock has marched upwards since announcing record revenues and a
Ormat Technologies Earnings: Steady Growth and a New Customer
Getting an encore performance from Ormat Technologies (NYSE: ORA) this past quarter wasn't likely after its impressive first quarter. This past quarter was good enough in its own right, though. The
Here's Why Apple Inc.'s OLED iPhone 8 Won't Include Touch ID
For the last month or so, there has been a lot of drama surrounding Apple's (NASDAQ: AAPL) upcoming premium OLED iPhone. The device had long been expected to include an in-display fingerprint scanner
How MobileIron Inc. Stock Fell 25% in July
Shares of MobileIron (NASDAQ: MOBL) fell 25.2% in July, according to data from S&P Global Market Intelligence.The maker of mobile data security tools for enterprise-class customers reported
Emergent Biosolutions Inc Diversifies Its Revenue
One knock on Emergent Biosolutions (NYSE: EBS) has always been its dependence on anthrax vaccine BioThrax, but management made good on its promise to diversify, moving toward its goal of having $1
Twitter's MAU Blues and Apple's New Highs
Two of the biggest names in tech recently reported their earnings and saw very different reactions from the market. While Apple's (NASDAQ: AAPL) earnings and guidance were incredibly strong, what few
bluebird bio Pauses During 2017 Data Blitz
Clinical-stage gene therapy specialist bluebird bio (NASDAQ: BLUE) reported second-quarter earnings last week, which mostly just served as a reminder of its pipeline progress because revenue and
The 2 Most Important Figures in Valeant's Second-Quarter Report (and Neither Is EPS or Debt)
Earnings season remains in full swing, and tomorrow morning, one of the most popular and embattled drugmakers in the entire market is set to reports its second-quarter results.Valeant Pharmaceuticals
Why Limelight Networks, Inc. Shares Rose 18% in July
Shares of Limelight Networks (NASDAQ: LLNW) gained 18.3% in July 2017, according to data from S&P Global Market Intelligence.The content delivery network operator saw share prices rising slowly
Here's Why Intrepid Potash Dropped as Much as 14.4% Today
Shares of fertilizer producer Intrepid Potash (NYSE: IPI) sank over 14% today after an analyst downgrade. The stock had been trading near two-year highs after the company released second-quarter 2017
Will Energy Transfer Partners LP Finally Turn the Corner in the Second Quarter?
Last quarter was more of the same for Energy Transfer Partners (NYSE: ETP). Despite completing a consolidation transaction with Sunoco Logistics, the company's cash flow slipped again in the first
Why Did Frontier Communications Corp. Shares Lose 12% in July?
For quite a while Frontier Communications (NASDAQ: FTR) has delivered nothing but bad news to its shareholders. The company has been slowly losing the subscribers in California, Texas, and Florida
What's Going on in BDC Land?
We're right in the middle of earnings season for the business development company industry, and there is a lot to talk about.From Oaktree Capital Group's (NYSE: OAK) plan to take over the Fifth Street
Starbucks Isn't Growing Like It Once Did
Starbucks (NASDAQ: SBUX) recently posted a growth uptick for its fiscal third quarter as its expansion pace improved to 4% from 3%. The coffee titan also boosted market share and managed key operating
Eldorado Gold Corp. Regained Its Shine and Jumped as Much as 10% -- Here's Why
Shares of Eldorado Gold (NYSE: EGO), a junior mining company with assets in Europe and South America, rocketed higher by as much as 10% during Monday's trading session. The reason for the sustained
Tesla to Raise $1.5 Billion in Debt: What You Need to Know
Following comments from management last week, Tesla (NASDAQ: TSLA) announced this morning that it intends to raise $1.5 billion in debt. CEO Elon Musk acknowledged on the earnings call that the